To: Ilaine who wrote (786 ) 10/3/2003 9:05:12 PM From: Henry Niman Respond to of 1070 Since there are so many media reports on the Taiwan revisions, it seems that a bit of analysis of the numbers posted on the website is in ordercdc.gov.tw The number of SARS deaths in Taiwan has been controversial because over 300 death certificates indicated the patient died of SARS, yet the number of deaths on the WHO site last month was only 180. Now that number has been "adjusted' down to 37 and the adjustments produce a number of highly questionable figures on the official Taiwan site, which have also been included in the latest WHO update. These numbers will not instill much confidence in many looking at the data scientifically. I have tried, without success, to get a clarification from WHO. The above site has taken the 180 deaths and put them into 3 categories. 107 are considered non-SARS cases because they are said to be negative for SARS CoV on BOTH antibody and PCR tests. 36 more deaths are said to be not directly due to SARS, even though the patients were SARS CoV positive. The remaining 37 are listed as deaths due directly to SARS CoV. Each of the categories has some glaring anomalies when compared to reports from just about any country with significant SARS cases and deaths. The two leading factors associated with SARS deaths are age and underlying disease. Taiwan seems to have used underlying disease as a reason for reclassifying some patients. But their own data shows that only 22 patients had underlying disease, so even if none of these are included in the 37 SARS deaths, there still are not enough patients with underlying disease to account for the 36 patients who are listed as "SARS-related". However, even more striking are the 107 deaths that are listed as being negative by BOTH PCR and antibody tests. The site seems to indicate that both tests were performed on 663/664 patients. That frequency of analysis seems rather high for PCR. However, the number is even more remarkable for antibody test on the 107 deceased patients who are said to be negative on BOTH tests, since the antibody tests is supposed to be run on samples collected at least 28 days after initial symptoms, and many SARS patients, especially older patients, die in less than 28 days post symptoms. Thus it would seem that many of the antibody tests on the 107 patients classified as non-SARS would be based on unreliable antibody data. Even more striking is the 33.8% case mortality rate in the SARS negative patients. The rate is much higher than the 10.7% rate for those who are SARS CoV positive and listed as SARS deaths or the 10.3% of those infected with SARS CoV but only classified as "SARS-related". A case mortality rate of 33.8% is about 10 X the case mortality rate of SARS CoV negative patients in Hong Kong. If the Taiwanese patients did not die of SARS, then they seem to have a mystery disease that presents as SARS, yet is much more lethal than the numbers for SARS patients infected with SARS CoV. In summary, that data on the official Taiwan site and on the revised WHO site appears to be extremely suspect. The testing frequency is remarkably high, patients are considered to be non-SARS even if they had SARS symptoms and died prior to 28 post symptoms, the non-SARS patients had an extraordinarily high case mortality rate, and there were not enough patients with underlying disease to account for the 36 "SARS related" deaths. Moreover, such revisions will make data comparisons with other countries meaningless. Alternatively, other countries will invoke their own unique interpretations to reduce the number of official SARS deaths, i.e. the index case for the Amoy Gardens outbreak initially tested positive for Influenza A. Therefore Hong Kong could reclassify all Amoy Gardens cases as flu cases that happened to be co-infected with SARS CoV. Government handling of the SARS epidemic is already suspect, as evidenced by responses to reports from Hong Kong and Toronto. The administrative adjustments at the Taiwan site will only increase mistrust of official explanations of the SARS epidemic.